INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
117 hedge funds and large institutions have $241M invested in Infinity Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
+2
Holders Change %
+1.74%
% of All Funds
3.12%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
22
Increased
36
Reduced
35
Closed
17
Calls
$1.38M
Puts
$850K
Net Calls
+$529K
Net Calls Change
-$1.28M
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$5.26M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.28M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.5M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$2.42M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$2.03M |
Top Sellers
| 1 |
ACM
Americafirst Capital Management
Roseville,
California
|
-$2.38B |
| 2 |
Goldman Sachs
New York
|
-$6.8M |
| 3 |
State Street
Boston,
Massachusetts
|
-$6.44M |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$5.71M |
| 5 |
O
OrbiMed
New York
|
-$3.65M |
